Ensayos clínicos de Sobrepeso en Alabama
31 estudios sobre Sobrepeso buscan participantes en Alabama.
Ciudades en Alabama
- Birmingham16 estudios
- Anniston6 estudios
- Huntsville4 estudios
- Mobile4 estudios
- Hoover3 estudios
- Dothan3 estudios
Texto oficial del estudio (inglés)
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Pinnacle Research Group, Anniston
- Alabama Clinical Therapeutics, Birmingham
- University of Alabama at Birmingham, Birmingham
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 nov 2026 · NCT07351045A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Lakeview Clinical Research, Guntersville
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 nov 2026 · NCT07351058Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
- AMR Clinical - Mobile, Mobile
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 nov 2026 · NCT07685808Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
- Cahaba Research, Inc., Pelham
ReclutandoFase 3
Edades de 18 a 99 · Todos los sexos · Actualizado el 6 nov 2026 · NCT07575399A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)
- Cullman Clinical Trials, Cullman
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT07823608A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity
- University of Alabama at Birmingham, Birmingham
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT07845500A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity
- Pinnacle Research Group, Anniston
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT07843498A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Pinnacle Research Group, LLC, Anniston
- Central Research Associates, Birmingham
- Cahaba Research - Pelham, Pelham
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT07794579A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Birmingham Clinical Research, Birmingham
- Cullman Clinical Trials, Cullman
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07282600A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- Birmingham Clinical Research, Birmingham
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07392190Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- AMR Clinical, Mobile
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07353931Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Digestive Health Specialists, Dothan
ReclutandoFase 3
Edades de 18 a 70 · Todos los sexos · Actualizado el 4 nov 2026 · NCT06937099A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- Cullman Clinical Trials, Cullman
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07369011Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Digestive Health Specialists, Dothan
ReclutandoFase 3
Edades de 18 a 70 · Todos los sexos · Actualizado el 4 nov 2026 · NCT06937086A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2 Diabetes (VESPER-OA 2)
- Central Alabama Research, Birmingham
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07915609A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Research Site, Dothan
- Research Site, Huntsville
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 oct 2026 · NCT07784725A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Fairhope
- Research Site, Huntsville
- Research Site, Mobile
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 oct 2026 · NCT07784270Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
- Cahaba Research - Pelham /ID# 282381, Pelham
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 27 oct 2026 · NCT07752979Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
- University of Alabama - Birmingham, Birmingham
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 26 oct 2026 · NCT07837973A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Birmingham
ReclutandoFase 3Se aceptan voluntarios sanos
Edades de 18 a 79 · Todos los sexos · Actualizado el 20 oct 2026 · NCT07654374Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes
- University of Alabama at Birmingham, Birmingham
Reclutando
Edades de 18 a 45 · Mujeres · Actualizado el 16 oct 2026 · NCT05124808A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Established Cardiovascular Disease
- Pinnacle Research Group, Anniston
ReclutandoFase 3
Edades de 40 en adelante · Todos los sexos · Actualizado el 7 oct 2026 · NCT07843472Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- Pinnacle Research Group LLC, Anniston
- Alliance For Multispecialty Research - Daphne, Daphne
- Alliance for Multispecialty Research Mobile, Mobile
ReclutandoFase 3
Edades de 18 a 99 · Todos los sexos · Actualizado el 5 oct 2026 · NCT07684235AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
- Pinnacle Research Group LLC, Anniston
- Univ of Alabama Birmingham, Birmingham
- Chambliss Clinical Trials LLC, Montgomery
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT07720271A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- MFA Clinical Research, Tuscaloosa
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07321886A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Birmingham
- AURORA-2 Clinical Site, Huntsville
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 sept 2026 · NCT07743450A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
- AURORA-1 Clinical Site, Birmingham
- AURORA-1 Clinical Site, Huntsville
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 sept 2026 · NCT07743463Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
- Uni of Alabama at Birmingham, Birmingham
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 sept 2026 · NCT07770841Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
- ACCOMPLISH-1 Research Site, Birmingham
- ACCOMPLISH-1 Research Site, Birmingham
ReclutandoFase 3
Edades de 18 a 79 · Todos los sexos · Actualizado el 10 ago 2026 · NCT07654361Time-restricted Eating for Postpartum Weight Loss
- University of Alabama at Birmingham, Birmingham
Reclutando
Edades de 18 en adelante · Mujeres · Actualizado el 29 jun 2026 · NCT06491537FELLAShip to Better Health
- The Worship Center Cristian Church, Birmingham
Reclutando
Edades de 18 en adelante · Hombres · Actualizado el 22 ene 2026 · NCT07220213De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.